Seven COVID-19 Patients Treated with C-Reactive Protein (CRP) Apheresis

Background: The fulminant course of COVID-19, triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), presents with a high mortality rate and still lacks a causative treatment. C-reactive protein (CRP) has been shown to increase dramatically during the disease progression and corr...

Descripción completa

Detalles Bibliográficos
Autores principales: Esposito, Fabrizio, Matthes, Harald, Schad, Friedemann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999883/
https://www.ncbi.nlm.nih.gov/pubmed/35407564
http://dx.doi.org/10.3390/jcm11071956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999883/
https://www.ncbi.nlm.nih.gov/pubmed/35407564
http://dx.doi.org/10.3390/jcm11071956

Ejemplares similares